1 Inserm U.563, Centre de Physiopathologie de Toulouse Purpan, Department of Oncogenesis and Signaling in Haematopoïetic Cells, IFR30, Hôpital Purpan, 31059 Toulouse, France
2 Laboratoire d'Hématologie, CHU Purpan, 31059 Toulouse, France
3 Inserm U.311, Etablissement Français du Sang-Alsace, 10 Rue Spielman, BP 36, 67065 Strasbourg, France
* Author for correspondence (e-mail: payrastr{at}toulouse.inserm.fr)
Accepted 16 November 2004
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Platelets, Lipid rafts, Actin, Cytoskeleton, Integrins, Phosphoinositides
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
At the sites of interaction with the cytoskeleton, the plasma membrane is subjected to important mechanical forces, especially during platelet fibrin clot retraction, a post-aggregation event involved in the maintenance of hemostasis. During retraction, integrins take part in the formation of a transmembrane linkage between proteins from the extracellular matrix and from the actomyosin filament network, allowing the transmission of contractile forces. It is currently hypothesized that the areas of membrane interacting with the cytoskeleton have a specific lipid composition adapted to these forces. In this context, cholesterol and sphingolipid enriched membrane microdomains, known as detergent resistant membranes (DRMs) or lipid rafts, are of major interest. Their lipid composition confers a restricted fluidity state called a liquid ordered phase to these membrane microdomains (Brown and London, 2000). Although the existence of rafts has been controversial in the past few years (Munro, 2003
), recent data place them at the forefront of cell biology and biomembrane research (del Pozo et al., 2004
; Sharma et al., 2004
). Interactions between rafts and cytoskeleton were proposed in various cell types (Brdickova et al., 2001
; Harder and Simons, 1999
; Laux et al., 2000
; Moran and Miceli, 1998
; Rozelle et al., 2000
; Villalba et al., 2001
). The actomyosin cytoskeleton seems to be involved in the lateral mobility of these microdomains (Seveau et al., 2001
) and the stabilization of raft platforms requires cytoskeleton rearrangements in their vicinity (Villalba et al., 2001
). However, the molecular mechanisms involved in raft-cytoskeleton interactions are still poorly documented. In platelets, lipid rafts were isolated on the basis of their insolubility in the non-ionic detergent Triton X-100 at 4°C and their low density (Bodin et al., 2001
; Bodin et al., 2003a
; Dorahy et al., 1996
). Strong evidence support their role in the early phases of signal transduction induced by Fc
RIIa (Bodin et al., 2003b
), the collagen receptor GpVI (Wonerow et al., 2002
) and the von Willebrand factor receptor GpIb-IX-V complex (Baglia et al., 2003
; Shrimpton et al., 2002
). However, the importance of rafts in post-integrin activation events as well as their potential interactions with the cytoskeleton remain unknown.
Interestingly, several years ago, a detergent-resistant pool of lipids was described in the cytoskeleton isolated from aggregated platelets (Hinchliffe et al., 1996; Livne et al., 1988
; Schick et al., 1983
; Tuszynski et al., 1984
; Zucker and Masiello, 1983
). The origin and the role of these `membrane fragments' are still unclear. Detergent resistance is considered as a valuable means to assess protein association with the cytoskeleton, but little is known about the relevance of a lipid-rich domain co-precipitating with the actin filaments upon cell activation. In this context, we decided to investigate in detail the interactions between the actin cytoskeleton and membrane domains and their functional roles during the late phases of platelet activation.
We demonstrated that a large fraction of DRMs specifically associated with the actin cytoskeleton upon platelet activation in an IIbß3-dependent manner. Although only a minor fraction of
IIbß3 was recovered in lipid rafts, this integrin induced a specific increase of phosphatidylinositol (4,5)-bisphosphate [PtdIns(4,5)P2] in rafts and the recruitment of several actin cytoskeleton regulatory proteins known to interact with this lipid. Moreover, we found that rafts are not mandatory for
IIbß3-mediated platelet aggregation upon high concentration of thrombin but we provide evidence for their role in platelet-mediated fibrin clot retraction. Thus,
IIbß3-mediated local modifications of cholesterol-rich membrane microdomains play an important role in the organization of the membrane-cytoskeleton linkage, through which tension forces may apply during the late phase of platelet activation.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Preparation and stimulation of platelets
Human platelets were isolated from concentrates obtained from the local blood bank (Etablissement Français du Sang, Pyrénées-Mediterranée). Platelets were washed twice in a washing buffer [140 mM NaCl, 5 mM KCl, 5 mM KH2PO4, 1 mM MgSO4, 10 mM HEPES pH 6.5, 5 mM glucose, 0.2% BSA (w/v)] and resuspended at 1.5x109 cells/ml in a stimulation buffer (washing buffer plus 1 mM CaCl2, pH 7.4). For inositol lipid analysis, platelets were labeled with 0.5 mCi/ml [32P]orthophosphate in a phosphate-free washing buffer (60 minutes, 37°C), washed and resuspended in the stimulation buffer (1.5x109 cells/ml). Platelet aggregation was monitored by a turbidimetric method as described previously (Gratacap et al., 1998). When indicated, wortmannin, RGDS and SR-121566 were used at 50 nM, 500 µM and 400 µM, respectively. For studies with platelets from three Glanzmann type I thrombasthenic patients, blood was anticoagulated with 124 mM tri-sodium citrate, 130 mM citric acid, 110 mM glucose at one volume for nine volumes of blood and centrifuged for 15 minutes at 190 g to obtain the platelet-rich plasma (PRP). Platelets were then washed as described above.
Clot retraction experiments
Clot retraction studies were performed as described (Schoenwaelder et al., 1997). Blood was drawn from healthy control donors, anticoagulated as described above and the platelet-rich plasma (PRP) was obtained as described above. Platelets were then washed as previously indicated and resuspended (3x108 cells/ml) without heparin in 2 ml of their autologous platelet-poor plasma containing 2 mM MgCl2 and 2 mM EGTA. They were activated with thrombin (0.5 IU/ml) and atroxin (0.1 µg/ml) or thrombin alone (2 IU/ml) under gentle shaking for 20 seconds at 37°C and the reaction mixtures were left unstirred for 2 hours at 37°C. The extent of clot retraction was quantified by measuring the residual volume of serum after removal of the fibrin clot and expressed as percentage of total reaction volume.
Isolation of the cytoskeleton fraction
Platelets (2x109 cells/ml) were lysed by addition of 0.5 ml of a 3x ice-cold cytoskeleton (CSK) lysis buffer [1.5% Triton X-100 (v/v), 3 mM PMSF, 3 mM Na3VO4, 6 µg/ml each of leupeptin and aprotinin, 60 mM EGTA and 300 mM Tris, pH 7.4] incubated for 10 minutes and centrifuged (15,000 g, 15 minutes, 4°C) to obtain the Triton X-100 insoluble low-speed pellet. This fraction was washed with 1x CSK lysis buffer and then with CSK lysis buffer without Triton X-100 to obtain the cytoskeleton.
Raft isolation procedures
Platelets (1.5x109 in 750 µl) were lysed by addition of 250 µl ice-cold 4x buffer [2% Triton X-100 (v/v), 150 mM NaCl, 100 mM Mes, pH 6.5, 3 mM PMSF, 3 mM Na3VO4, 8 µg/ml each of leupeptin and aprotinin] and incubated for 5 minutes. Procedures were performed at 4°C as described (Bodin et al., 2001). The 1.5 ml lysate was adjusted to 1.37 M (40%) sucrose by addition of 1 ml of 2.74 M sucrose prepared in Mes-buffered saline (MBS) (150 mM NaCl, 25 mM Mes, pH 6.5, 1 mM PMSF, 1 mM Na3VO4). A step sucrose gradient was made by successive additions of 1 M (30%), 0.8 M (25%), 0.6 M (20%), 0.5 M (15%), 0.3 M (10%), 0.15 M (5%) sucrose solution (1.33 ml each) on the top of the 1.37 M (40%) homogenate. The gradients were ultracentrifuged (200,000 g, 4°C, 16 hours) and eight fractions of equal volume were harvested from the top. Rafts were recovered mainly in fractions 2-4. When rafts were isolated from the cytoskeleton fraction, the Triton X-100 insoluble low speed pellet was first incubated with 1 ml of 0.6 M KI (30 minutes, 4°C) in order to depolymerize actin filaments (Payrastre et al., 1991
). Then, 1 ml of the 2.74 M sucrose solution was added, and rafts were isolated as described above. For analysis of the protein content in rafts, the gradient fractions 2 to 4 were pooled. Proteins were precipitated with trichloroacetic acid and resuspended in Laemmli buffer. Western blot experiments were performed using the relevant antibodies, peroxidase-conjugated secondary antibodies and the ECL system. When indicated, quantifications were performed using NIH Image J software.
Cholesterol depletion experiments
Controlled cholesterol depletion treatments were performed as previously described (Bodin et al., 2001). Platelets (1x109 cells/ml) were incubated in the washing buffer containing 5 mM methyl-ß-cyclodextrin MßCD) (10 minutes), washed and resuspended in the stimulation buffer. The cholesterol levels before and after depletion were quantified by gas chromatography (Bodin et al., 2001
).
Major phospholipid and cholesterol quantification
Lipids were extracted from the cytoskeleton fraction or the isolated rafts following the acidified Bligh and Dyer method (Bligh and Dyer, 1959). Sphingomyelin (SM), phosphatidylcholine (PC), phosphatidylserine (PS) and phosphatidylethanolamine (PE) were separated by TLC using CHCl3/CH3OH/CH3COOH/H2O (75/45/12/6, v/v), identified by iodine vapor staining, in reference to lipid standards and scraped off. The quantification was performed according to phosphorus content as previously described (Bodin et al., 2001
). Cholesterol quantification was performed by gas chromatography.
Phosphoinositide analysis
[32P]-labeled lipids were extracted from whole platelets or isolated rafts following the acidified Bligh and Dyer method (Bligh and Dyer, 1959) and resolved by TLC using CHCl3/CH3COCH3/CH3COOH/H2O 80/30/26/24/14 (v/v). Spots corresponding to [32P]PtdInsP2 were visualized with a PhosphorImager 445 SI (Molecular Dynamics) scraped off, deacylated by 20% methylamine and analyzed by high performance liquid chromatography (HPLC) on a Whatman Partisphere 5 SAX column (Whatman International Ltd., UK) as described (Gratacap et al., 1998
).
PtdIns(4)P 5-kinase in vitro assay
Rafts isolated from platelets (1.5x109 cells/gradient) were diluted three times in MBS, pelleted by ultracentrifugation (100,000 g, 1.5 hours, 4°C, Rotor 60 Ti, Beckmann), resuspended in Tris-HCl (50 mM, pH 7.4) and incubated at 37°C for 20 minutes with PtdIns(4)P/PS sonicated vesicles (20 µg/40 µg) and 2x kinase buffer (100 mM Tris HCl, 3 mM DTT, 200 mM NaCl, 20 mM MgCl2, 1 mM EDTA, 100 µM ATP and 30 µCi [-32P]ATP) with gentle shaking. The reaction was stopped by addition of CHCl3/CH3OH (v/v) and lipids were immediately extracted. The [32P]PtdIns(4,5)P2 produced was quantified as described above.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
In resting platelets, most of the rafts were recovered in the `Triton-X100 soluble fraction' (Fig. 2C) corresponding to the supernatant as defined in Fig. 2A. This observation indicates that rafts do not associate with the cytoskeleton in resting platelets and that they do not sediment in the presence of 1% Triton-X100 by low speed centrifugation (15,000 g, 30 minutes, 4°C). Furthermore, after high-speed centrifugation of the `Triton X-100 soluble fraction' (100,000 g, 60 minutes, 4°C), a procedure classically used to sediment the membrane skeleton (Fox, 1993), rafts were not pelleted, as judged by the absence of cholesterol and SM in the pellet (not shown). After thrombin stimulation, a large fraction of lipid rafts associated to the platelet cytoskeleton with a concomitant decrease of their presence in the supernatant (Fig. 2C).
To rule out any non-specific trapping of lipid rafts into the newly polymerized actin filaments of activated platelets, we added radioactively labeled rafts isolated from [32P]-labeled platelets stimulated with thrombin, to the lysate of unlabeled thrombin-activated platelets. All raft-resident phospholipid classes were labeled with [32P] and no significant exchange between exogenous radio-labeled lipids and endogenous ones could be observed as illustrated by the stability of the lipid composition of labeled rafts for at least 15 minutes at 4°C under these conditions (not shown). After a 10-minute incubation at 4°C, this mix was subjected to the classical cytoskeleton isolation procedure (as defined in Fig. 2A). The large majority (72 and 74%, n=2) of exogenous [32P]-labeled rafts remained in the supernatant. Altogether, these data strongly suggest the existence of a specific and regulated interaction of rafts with the cytoskeleton during platelet activation.
The association of lipid rafts with the actin cytoskeleton requires IIbß3 engagement
The engagement of IIbß3 integrins induced through the binding of fibrinogen is a key event for platelet aggregation. In human platelets, thrombin is a potent agonist that activates protease activated receptors (PARs) 1 and 4 and interacts with GpIb. To show that activation of PAR1 is sufficient to induce raft-cytoskeleton interaction, we stimulated platelets with the TRAP peptide. As expected, RGDS, the antagonist for fibrinogen binding to
IIbß3, abolished platelet aggregation induced by stimulation of PAR1 with TRAP (Fig. 3A, left panel) whereas actin cytoskeleton reorganization still occurred to a large extent (Fig. 3A, right panel). Interestingly, the amounts of cholesterol and SM associated with the actin cytoskeleton, reflecting the presence of lipid rafts, were dramatically reduced upon RGDS treatment (Fig. 3B). A similar result was obtained with the compound SR-121566 (Fig. 3B), another competitive antagonist for fibrinogen binding to
IIbß3 that prevents platelet aggregation (Savi et al., 2001
).
|
This IIbß3-mediated raft-cytoskeleton interaction was further analyzed by isolating DRMs from whole platelets and measuring the amount of bound F-actin. Trace amounts of actin were observed in rafts from resting platelets, but a dramatic increase in actin was found in rafts upon TRAP stimulation (Fig. 3C). This association correlated with a shift of rafts to a higher density in sucrose gradients (Fig. 3C). Inhibition of fibrinogen binding to
IIbß3 by pretreatment with RGDS or SR-121566 inhibited both the increase of actin level in rafts and the shift of rafts in the density gradient (Fig. 3C). Similar results were obtained using another raft isolation procedure (Drevot et al., 2002
) performed at 37°C in the presence of Brij 98 as a detergent (not shown) indicating that this association was not due to a lipid phase transition occurring at 4°C.
To prove the role of IIbß3 in the association of rafts with the cytoskeleton, we used platelets from type I Glanzmann thrombastenia patients, a disease characterized by the absence of
IIbß3 (Nair et al., 2002
). As expected, the
IIbß3-deficient platelets were unable to aggregate in response to the potent agonist thrombin (not shown) and partially reorganized their actin cytoskeleton (Fig. 4A). The amounts of CD36, LAT and cholesterol (Fig. 4A,B) did not increase significantly in the cytoskeleton of activated Glanzmann thrombastenic platelets indicating a lack of raft association. The lipid composition analysis was limited to cholesterol because of the sample size. The amount of SM could, however, be measured in a sample from one patient and was also very low (3 nM) in the cytoskeleton (from 3x109 cells) upon activation. This critical role of
IIbß3 in raft-cytoskeleton association prompted us to check for the presence of integrin in these microdomains. In agreement with a recent study (Wonerow et al., 2002
), only a minor pool (10±5%, n=3) of ß3 integrin subunit was recovered in lipid rafts upon TRAP stimulation of normal platelets (Fig. 4C).
|
The raft-cytoskeleton association is reversible
As indicated by the quantification of cholesterol and SM in the cytoskeleton, the extent of raft-cytoskeleton association followed the aggregation amplitude and remained stable during an irreversible aggregation (see Fig. 5A,B). We then investigated this association during a pharmacologically induced reversible platelet aggregation. Inhibition of PI 3-kinase by addition of wortmannin shortly (2 minutes) after TRAP stimulation is known to induce a rapid reversion of platelet aggregation without significantly affecting the actin polymerization (Kovacsovics et al., 1995; Trumel et al., 1999
). Under these conditions (Fig. 5B), we observed a rapid dissociation of lipid rafts from the actin cytoskeleton. The SR-121566 compound is known to displace the fibrinogen bound to
IIbß3 and to induce the reversion of aggregation (Savi et al., 2001
). When SR-121566 was added to the platelet suspension 1.5 minutes after TRAP stimulation, the platelet disaggregation (Fig. 5A) was again accompanied by a dissociation of rafts from the actin cytoskeleton (Fig. 5B). These data indicate that the raft-cytoskeleton interaction is a dynamic and reversible process requiring a stable
IIbß3-mediated platelet aggregation.
|
IIbß3 upregulates the PtdIns(4,5)P2 level specifically in rafts and the concomitant recruitment of actin regulatory proteins known to directly or indirectly interact with this lipid
PtdIns(4,5)P2 plays important roles in regulating actin assembly as well as interactions between membranes and cytoskeleton (Raucher et al., 2000; Sechi and Wehland, 2000
). This lipid interacts with and regulates the activity of many actin modulating proteins such as the ERMs (ezrin, radixin, moesin) proteins acting as a link between transmembrane proteins an actin filaments, and the nucleation promoting factors (NPFs) of the WASP family proteins (Wiskott Aldrich Syndrome proteins) that activate the Arp2/3 complex (Actin-related protein 2/3 complex) (Higgs and Pollard, 2001
). Interestingly, a pool of PtdIns(4,5)P2 has been previously described in rafts (Bodin et al., 2001
; Pike and Casey, 1996
) and the modulation of its level has been proposed to participate in actin accumulation in the vicinity of these microdomains (Laux et al., 2000
). Therefore, we checked whether the amount of PtdIns(4,5)P2 in rafts was modulated by an
IIbß3 engagement-dependent process. As shown in Fig. 6A, 3 minutes after TRAP stimulation, the [32P]-PtdIns(4,5)P2 level significantly increased in rafts (3.0±0.8 fold) and was sustained up to 6.5 minutes of stimulation (2.9±0.8 fold). The amount of other phospholipids (SM, PC, PS and PE) in rafts did not change upon stimulation (not shown) indicating a selective effect of
IIbß3. In whole platelets, the amount of [32P]PtdIns(4,5)P2 did not change significantly upon TRAP stimulation indicating that the increase was specific for rafts (Fig. 6A). Furthermore, when platelets were pretreated with SR-121566 or RGDS (Fig. 6A), the increase in [32P]PtdIns(4,5)P2 in rafts was inhibited indicating its requirement for
IIbß3 engagement. Accordingly, the PtdIns(4)P 5-kinase activity measured in isolated rafts increased fivefold upon TRAP stimulation in an
IIbß3 engagement-dependent manner (Fig. 6B, upper panel). This is consistent with the
IIbß3-dependent recruitment in raft of a fraction (10% of total) of the small GTPase Rac (Fig. 6B, lower panel). Indeed, Rac is known to associate and activate PtdInsP 5-kinase I
(Chatah and Abrams, 2001
) leading to the production of a pool of PtdIns(4,5)P2 involved in actin assembly in platelets (Tolias et al., 2000
).
|
Several proteins involved in the re-organization of the actin cytoskeleton and known to be regulated directly or indirectly by PtdIns(4,5)P2 associated with rafts in an IIbß3-dependent manner (Fig. 6C). This was the case for the only ERM protein expressed in platelets, moesin (14% of total), which is involved in cytoskeleton rearrangements, lamellipodia and filopodia formation (Shcherbina et al., 1999
) (Fig. 6C). Cdc42 (11% of total), a small GTPase of the Rho family highly expressed in platelets (Azim et al., 2000
) was also recruited to rafts in an
IIbß3-dependent manner (Fig. 6B) whereas RhoA, also abundantly expressed in platelets, did not (not shown). VASP (vasodilator-stimulated phosphoprotein) (18% of the total) and the Arp3 subunit of the Arp2/3 complex (11% of the total) known to promote actin nucleation and branching (Higgs and Pollard, 2001
) (Fig. 6C) were recruited to the microdomains in the same way. However, we were unable to detect the presence of WASP suggesting that the recruitment of the Arp2/3 complex was mediated by another NPF such as N-WASP or Scar/WAVE. Furthermore, under 50% cholesterol depletion by MßCD, the increase in PtdIns(4,5)P2 in the disorganized rafts did not occur upon TRAP stimulation and the association of these microdomains with the cytoskeleton was largely abolished (not shown), whereas actin polymerization was only partly affected (12% inhibition). Altogether, these results point to PdIns(4,5)P2 as a key component of the
IIbß3-mediated cytoskeleton-rafts interaction in platelets.
The integrity of lipid rafts is required for fibrin clot retraction
Irreversible platelet aggregation and fibrin clot retraction are two post-integrin engagement events that require firm membrane-cytoskeleton interactions. To investigate the role of lipid rafts in these processes, we performed a controlled cholesterol depletion (50±2% depletion of total cholesterol) using MßCD in order to disorganize these microdomains (Bodin et al., 2001; Bodin et al., 2003b
; Pizzo et al., 2002
). Disruption of rafts was illustrated by the sharp decrease in CD36 and LAT levels in the light density fractions of the sucrose gradients (Fig. 7A). As previously published (Bodin et al., 2001
; Bodin et al., 2003b
), cholesterol depletion affected early platelet responses induced by stimulation with low (0.2 IU/ml) concentrations of thrombin (Fig. 7A) or TRAP (5-40 µM) (not shown). At high thrombin concentrations (
0.5 IU/ml) the intensity and the stability of the aggregation response was not affected by raft disorganization indicating that the microdomains are not mandatory for
IIbß3-mediated platelet aggregation.
|
We then examined the cellular retraction of fibrin clots in a washed platelet assay system. Platelet stimulation by thrombin (0.5 IU/ml) in the presence of atroxin, an N-terminal fibrinopeptide A cleaving snake venom enzyme (Meh et al., 1995), or by thrombin alone at high concentration (2 IU/ml) resulted in retraction of fibrin clots (Fig. 7B). This clot retraction was strongly inhibited by cholesterol depletion and raft disruption. One way of evaluating the extent of clot retraction is to measure the residual volume of serum after removal of the clot. Disorganization of lipid rafts led to a significant reduction of clot retraction (30±5% when platelets were stimulated by 0.5 IU/ml thrombin in the presence of atroxin and 39±12% when they were stimulated with thrombin alone; P<0.01, n=3). This result suggests that lipid rafts are involved in the organization of a functional membrane scaffold involved in the efficiency of actomyosin contraction.
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We found that in resting platelets, rafts did not sediment by high-speed centrifugation in the presence of 1% Triton X-100 excluding an eventual association with the membrane skeleton (Fox, 1993). Upon platelet stimulation, the interaction of rafts with the cytoskeleton paralleled the aggregation process, was delayed compared to the rapid and massive actin assembly induced by thrombin or TRAP (S.B. and B.P., personal observation) and did not result from non-specific trapping in newly polymerized actin filaments. The raft-cytoskeleton interaction was also observed when the DRMs were directly isolated from thrombin-stimulated platelets by the conventional method. Under these conditions, a significant amount of F-actin was found associated with the microdomains and correlated with a slight increase in raft density. Interestingly, competitors of fibrinogen binding to
IIbß3 integrins strongly inhibited the raft-cytoskeleton interaction under conditions that preserved a large part of the agonist-mediated cytoskeleton reorganization. The critical role of
IIbß3 in this process was confirmed using Glanzman's thrombastenic platelets lacking this integrin (Nair et al., 2002
). The extent of cytoskeleton-raft interaction paralleled the platelet aggregation intensity and was stable during an irreversible aggregation. Under conditions where platelet aggregation was reversed by addition of either SR-121566, a potent fibrinogen binding antagonist (Savi et al., 2001
), or PI 3-kinase inhibitors (Trumel et al., 1999
) after TRAP stimulation, the raft-cytoskeleton association became reversible. Thus, both the initiation and the stability of this interaction require sustained
IIbß3 engagement and a stable aggregation.
The existence of raft-cytoskeleton interactions were previously shown in nucleated cells (Brdickova et al., 2001; Harder and Simons, 1999
; Laux et al., 2000
; Moran and Miceli, 1998
; Rozelle et al., 2000
; Villalba et al., 2001
). In lymphocytes, a T-cell receptor (TCR)-CD44 co-stimulation participates in the Rac-dependent actin-mediated clustering of lipid rafts (Foger et al., 2001
). The F-actin dependent spatial reorganization at the immune synapse was shown to involve the Vav1/Rac pathway (Villalba et al., 2001
). It was recently demonstrated in fibroblasts that Rac1 targeting to lipid rafts is controlled by integrin signals, and local regulation of rafts by integrins as a cause of the recruitment of signaling molecules involved in anchorage-dependent growth was proposed (del Pozo et al., 2004
). Interestingly, upon TRAP stimulation, we measured a significant
IIbß3-dependent increase in PtdIns(4)P 5-kinase activity in platelet rafts and a concomitant production of PtdIns(4,5)P2 specifically in these microdomains. This is consistent with a previous study reporting an increase in PtdIns(4,5)P2 in the cytoskeleton isolated from thrombin-stimulated platelets (Hinchliffe et al., 1996
). Moreover, a PtdInsP 5-kinase I
activated by Rac was shown to translocate to membranes upon thrombin PAR1 receptor stimulation (Chatah and Abrams, 2001
) and to produce a pool of PtdIns(4,5)P2 involved in actin assembly (Tolias et al., 2000
). Thus, the integrin-dependent recruitment of Rac to lipid rafts observed in activated platelets and in other cell types (del Pozo et al., 2004
) may be essential for the regulation of this localized production of PtdIns(4,5)P2. PtdIns(4,5)P2 raft-modulating proteins (Laux et al., 2000
) such as the myristoylated alanine-rich C-kinase substrate MARCKS which is present in platelets (Elzagallaai et al., 2000
), may also play a role in the recruitment or in the stabilization of these PtdIns(4,5)P2 pools. The regulation of PtdIns(4,5)P2 in membrane domains is particularly important for dynamic processes linked to the organization of the cytoskeleton. This phosphoinositide has been shown to induce the actin-based movement of raft-enriched intracellular vesicles (Rozelle et al., 2000
). In neuronal cells, GAP43-like proteins, a group of PtdIns(4,5)P2 raft-modulating proteins, accumulate at the inner leaflet of rafts where they concentrate PtdIns(4,5)P2 and then promote F-actin assembly (Laux et al., 2000
). We show here that, concomitant with the increase of PtdIns(4,5)P2 in the microdomains, several proteins known to interact directly or indirectly with this phosphoinositide, and which are involved in actin cytoskeleton organization, relocated to lipid rafts in an
IIbß3-dependent manner. For example, the association of Arp3 with rafts upon platelet aggregation suggests the presence of the actin branching and nucleating Arp2/3 complex which is known to be activated by WASP and N-WASP, which are themselves stimulated by PtdIns(4,5)P2 and Cdc42 (Higgs and Pollard, 2001
). We also detected recruitment of the ERM protein moesin whose activity is modulated by an interaction with PtdIns(4,5)P2 (Barret et al., 2000
) and that acts as a crosslinker between actin filaments and the plasma membrane. Consequently, moesin participates notably in cell-cell adhesion processes (Mangeat et al., 1999
) and such a role in platelets has recently been suggested via interaction with PECAM-1 (Gamulescu et al., 2003
), a protein that we detected in rafts (not shown). The major role for
IIbß3 in regulating the recruitment of actin cytoskeleton modulating proteins to rafts, resulting in a strong interaction with the actin network of activated platelets, contrasts with the low level of
IIbß3 found in these microdomains. Using different methods, Wonerow and colleagues found very low levels of activated
IIbß3 in DRMs and showed that early tyrosine phosphorylation events downstream of
IIbß3 engagement do not require lipid raft integrity (Wonerow et al., 2002
). A recent report (Heijnen et al., 2003
) described cholesterol-rich membrane domains concentrated at the tips of filopodia and at the leading edge of spreading platelets interacting with a fibrinogen coated surface. Interestingly, this
IIbß3-dependent spreading on fibrinogen (Litjens et al., 2003
) required raft integrity (Heijnen et al., 2003
). Thus, despite its apparent low affinity for rafts,
IIbß3 can, under certain conditions, regulate raft-dependent events including a local increase in PtdIns(4,5)P2, which may then play an important role in anchoring the microdomains to the actin filament system.
IIbß3 could localize in the vicinity of the microdomains (Wonerow et al., 2002
), possibly via an association with raft-resident proteins such as tetraspanins (Berditchevski, 2001
) while having a higher affinity for the actin cytoskeleton than for rafts. These data also raise the question of the communication between molecules located outside and inside rafts. This area of research remains to be investigated and may implicate the lateral mobility of particular lipids and membrane proteins in and out of raft and non-raft membrane areas.
What is the role of raft-cytoskeleton interactions in post-integrin engagement events? The present study demonstrates that disruption of raft integrity by controlled cholesterol depletion does not prevent platelet aggregation induced by high thrombin concentrations. Thus, IIbß3 inside-out and outside-in signaling can function, at least in part, independently of lipid rafts as previously proposed (Wonerow et al., 2002
). However, we found that fibrin clot retraction, a post-aggregation event requiring
IIbß3 engagement, was strongly affected by raft disruption. The interaction of the actin cytoskeleton with membrane domains with a restricted fluidity state may be well adapted to develop
IIbß3-mediated tension forces during the late phase of platelet activation. Although the molecular mechanisms leading to clot retraction are still poorly characterized, this final step of hemostasis is thought to be important for the mechanical stability of thrombi under conditions of high shear stress and may provide less surface area for fibrinolytic proteins.
In conclusion, our study demonstrates for the first time the existence of a strong and specific IIbß3-dependent interaction of lipid rafts with the actin cytoskeleton in activated human platelets. In addition to the previously described raft-cytoskeleton interaction driven by the immune receptors and their partners, we show the existence of a novel mechanism involving integrins. We propose a model where
IIbß3, although mainly located outside the rafts, controls the level of PtdIns(4,5)P2 in the microdomains and the local rearrangement of the actin cytoskeleton. Although rafts are not mandatory for
IIbß3-mediated platelet aggregation, they appear to play an important role in clot retraction. Thus, the raft-cytoskeleton interaction may participate in the organization of
IIbß3-mediated tension forces required for this post-aggregation event. Whether the raft-cytoskeleton interaction also plays a role in other cellular processes such as adhesion, cell-cell contact or cell migration involving different integrins represents an important area for future investigation.
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Azim, A. C., Barkalow, K., Chou, J. and Hartwig, J. H. (2000). Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor. Blood 95, 959-964.
Baglia, F. A., Shrimpton, C. N., Lopez, J. A. and Walsh, P. N. (2003). The glycoprotein Ib-IX-V complex mediates localization of factor XI to lipid rafts on the platelet membrane. J. Biol. Chem. 278, 21744-21750.
Barret, C., Roy, C., Montcourrier, P., Mangeat, P. and Niggli, V. (2000). Mutagenesis of the phosphatidylinositol 4,5-bisphosphate (PIP(2)) binding site in the NH(2)-terminal domain of ezrin correlates with its altered cellular distribution. J. Cell Biol. 151, 1067-1080.
Berditchevski, F. (2001). Complexes of tetraspanins with integrins: more than meets the eye. J. Cell Sci. 114, 4143-4151.
Bligh, E. G. and Dyer, W. J. (1959). A rapid method of total lipid extraction and purification. Can. J. Biochem. Phys. 37, 911-917.
Bodin, S., Giuriato, S., Ragab, J., Humbel, B. M., Viala, C., Vieu, C., Chap, H. and Payrastre, B. (2001). Production of phosphatidylinositol 3,4,5-trisphosphate and phosphatidic acid in platelet rafts: evidence for a critical role of cholesterol-enriched domains in human platelet activation. Biochemistry 40, 15290-15299.[CrossRef][Medline]
Bodin, S., Tronchere, H. and Payrastre, B. (2003a). Lipid rafts are critical membrane domains in blood platelet activation processes. Biochim. Biophys. Acta 1610, 247-257.[Medline]
Bodin, S., Viala, C., Ragab, A. and Payrastre, B. (2003b). A critical role of lipid rafts in the organization of a key FcgammaRIIa-mediated signaling pathway in human platelets. Thromb. Haemost. 89, 318-330.[Medline]
Brdickova, N., Brdicka, T., Andera, L., Spicka, J., Angelisova, P., Milgram, S. L. and Horejsi, V. (2001). Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton. FEBS Lett. 507, 133-136.[CrossRef][Medline]
Brown, D. A. and London, E. (2000). Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275, 17221-17224.
Brown, D. A. and Rose, J. K. (1992). Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68, 533-544.[Medline]
Chatah, N. E. and Abrams, C. S. (2001). G-protein-coupled receptor activation induces the membrane translocation and activation of phosphatidylinositol-4-phosphate 5-kinase I alpha by a Rac- and Rho-dependent pathway. J. Biol. Chem. 276, 34059-34065.
del Pozo, M. A., Alderson, N. B., Kiosses, W. B., Chiang, H. H., Anderson, R. G. and Schwartz, M. A. (2004). Integrins regulate Rac targeting by internalization of membrane domains. Science 303, 839-842.
Dorahy, D. J., Berndt, M. C., Shafren, D. R. and Burns, G. F. (1996). CD36 is spatially associated with glycoprotein IIb-IIIa (alpha IIb beta 3) on the surface of resting platelets. Biochem. Biophys. Res. Commun. 218, 575-581.[CrossRef][Medline]
Drevot, P., Langlet, C., Guo, X. J., Bernard, A. M., Colard, O., Chauvin, J. P., Lasserre, R. and He, H. T. (2002). TCR signal initiation machinery is pre-assembled and activated in a subset of membrane rafts. EMBO J. 21, 1899-1908.
Elzagallaai, A., Rose, S. D. and Trifaro, J. M. (2000). Platelet secretion induced by phorbol esters stimulation is mediated through phosphorylation of MARCKS: a MARCKS-derived peptide blocks MARCKS phosphorylation and serotonin release without affecting pleckstrin phosphorylation. Blood 95, 894-902.
Engqvist-Goldstein, A. E. and Drubin, D. G. (2003). Actin assembly and endocytosis: from yeast to mammals. Annu. Rev. Cell Dev. Biol. 19, 287-332.
Fais, S. and Malorni, W. (2003). Leukocyte uropod formation and membrane/cytoskeleton linkage in immune interactions. J. Leukoc. Biol. 73, 556-563.
Foger, N., Marhaba, R. and Zoller, M. (2001). Involvement of CD44 in cytoskeleton rearrangement and raft reorganization in T cells. J. Cell Sci. 114, 1169-1178.
Fox, J. E. (1993). The platelet cytoskeleton. Thromb. Haemost. 70, 884-893.[Medline]
Gamulescu, M. A., Seifert, K., Tingart, M., Falet, H. and Hoffmeister, K. M. (2003). Platelet moesin interacts with PECAM-1 (CD31). Platelets 14, 211-217.[CrossRef][Medline]
Gratacap, M. P., Payrastre, B., Viala, C., Mauco, G., Plantavid, M. and Chap, H. (1998). Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation of phospholipase C-gamma2 is an early key event in FcgammaRIIA-mediated activation of human platelets. J. Biol. Chem. 273, 24314-24321.
Harder, T. and Simons, K. (1999). Clusters of glycolipid and glycosylphosphatidylinositol-anchored proteins in lymphoid cells: accumulation of actin regulated by local tyrosine phosphorylation. Eur. J. Immunol. 29, 556-562.[CrossRef][Medline]
Hartwig, J. H., Barkalow, K., Azim, A. and Italiano, J. (1999). The elegant platelet: signals controlling actin assembly. Thromb. Haemost. 82, 392-398.[Medline]
Heijnen, H. F., van Lier, M., Waaijenborg, S., Ohno-Iwashita, Y., Waheed, A. A., Inomata, M., Gorter, G., Mobius, W., Akkerman, J. W. and Slot, J. W. (2003). Concentration of rafts in platelet filopodia correlates with recruitment of c-Src and CD63 to these domains. J. Thromb. Haemost. 1, 1161-1173.[CrossRef][Medline]
Higgs, H. N. and Pollard, T. D. (2001). Regulation of actin filament network formation through ARP2/3 complex: activation by a diverse array of proteins. Annu. Rev. Biochem. 70, 649-676.[CrossRef][Medline]
Hinchliffe, K. A., Irvine, R. F. and Divecha, N. (1996). Aggregation-dependent, integrin-mediated increases in cytoskeletally associated PtdInsP2 (4,5) levels in human platelets are controlled by translocation of PtdIns 4-P 5-kinase C to the cytoskeleton. EMBO J. 15, 6516-6524.[Abstract]
Kovacsovics, T. J., Bachelot, C., Toker, A., Vlahos, C. J., Duckworth, B., Cantley, L. C. and Hartwig, J. H. (1995). Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation. J. Biol. Chem. 270, 11358-11366.
Laux, T., Fukami, K., Thelen, M., Golub, T., Frey, D. and Caroni, P. (2000). GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J. Cell Biol. 149, 1455-1472.
Litjens, P. E., Kroner, C. I., Akkerman, J. W. and van Willigen, G. (2003). Cytoplasmic regions of the beta3 subunit of integrin alphaIIbbeta3 involved in platelet adhesion on fibrinogen under flow conditions. J. Thromb. Haemost. 1, 2014-2021.[CrossRef][Medline]
Livne, A., Packham, M. A., Guccione, M. A. and Mustard, J. F. (1988). Aggregation-related association of lipid with the cytoskeleton of rabbit and human platelets prelabeled with [3H]palmitic acid. Similar effects of adenosine diphosphate- and thrombin-induced aggregation. J. Clin. Invest. 81, 288-299.[Medline]
Mangeat, P., Roy, C. and Martin, M. (1999). ERM proteins in cell adhesion and membrane dynamics. Trends Cell Biol. 9, 187-192.[CrossRef][Medline]
Meh, D. A., Siebenlist, K. R., Bergtrom, G. and Mosesson, M. W. (1995). Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin. J. Lab. Clin. Med. 125, 384-391.[Medline]
Moran, M. and Miceli, M. C. (1998). Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: a role for lipid rafts in T cell activation. Immunity 9, 787-796.[Medline]
Munro, S. (2003). Lipid rafts: elusive or illusive? Cell 115, 377-388.[Medline]
Nair, S., Ghosh, K., Kulkarni, B., Shetty, S. and Mohanty, D. (2002). Glanzmann's thrombasthenia: updated. Platelets 13, 387-393.[CrossRef][Medline]
Payrastre, B., van Bergen en Henegouwen, P. M., Breton, M., den Hartigh, J. C., Plantavid, M., Verkleij, A. J. and Boonstra, J. (1991). Phosphoinositide kinase, diacylglycerol kinase, and phospholipase C activities associated to the cytoskeleton: effect of epidermal growth factor. J. Cell Biol. 115, 121-128.[Abstract]
Pike, L. J. and Casey, L. (1996). Localization and turnover of phosphatidylinositol 4,5-bisphosphate in caveolin-enriched membrane domains. J. Biol. Chem. 271, 26453-26456.
Pizzo, P., Giurisato, E., Tassi, M., Benedetti, A., Pozzan, T. and Viola, A. (2002). Lipid rafts and T cell receptor signaling: a critical re-evaluation. Eur. J. Immunol. 32, 3082-3091.[CrossRef][Medline]
Ragab, A., Bodin, S., Viala, C., Chap, H., Payrastre, B. and Ragab-Thomas, J. (2003). The tyrosine phosphatase 1B regulates linker for activation of T-cell phosphorylation and platelet aggregation upon FcgammaRIIa cross-linking. J. Biol. Chem. 278, 40923-40932.
Raucher, D., Stauffer, T., Chen, W., Shen, K., Guo, S., York, J. D., Sheetz, M. P. and Meyer, T. (2000). Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion. Cell 100, 221-228.[Medline]
Rozelle, A. L., Machesky, L. M., Yamamoto, M., Driessens, M. H., Insall, R. H., Roth, M. G., Luby-Phelps, K., Marriott, G., Hall, A. and Yin, H. L. (2000). Phosphatidylinositol 4,5-bisphosphate induces actin-based movement of raft-enriched vesicles through WASP-Arp2/3. Curr. Biol. 10, 311-320.[CrossRef][Medline]
Savi, P., Zamboni, G., Rescanieres, O. and Herbert, J. M. (2001). Studies on the binding of 3H-SR121566, an inhibitor of Gp IIb-IIIa activation. Thromb. Haemost. 85, 702-709.[Medline]
Schick, P. K., Tuszynski, G. P. and Vander Voort, P. W. (1983). Human platelet cytoskeletons: specific content of glycolipids and phospholipids. Blood 61, 163-166.[Abstract]
Schoenwaelder, S. M., Yuan, Y., Cooray, P., Salem, H. H. and Jackson, S. P. (1997). Calpain cleavage of focal adhesion proteins regulates the cytoskeletal attachment of integrin alphaIIbbeta3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin clots. J. Biol. Chem. 272, 1694-1702.
Sechi, A. S. and Wehland, J. (2000). The actin cytoskeleton and plasma membrane connection: PtdIns(4,5)P(2) influences cytoskeletal protein activity at the plasma membrane. J. Cell Sci. 113, 3685-3695.
Seveau, S., Eddy, R. J., Maxfield, F. R. and Pierini, L. M. (2001). Cytoskeleton-dependent membrane domain segregation during neutrophil polarization. Mol. Biol. Cell 12, 3550-3562.
Sharma, P., Varma, R., Sarasij, R. C., Ira, Gousset, K., Krishnamoorthy, G., Rao, M. and Mayor, S. (2004). Nanoscale organization of multiple GPI-anchored proteins in living cell membranes. Cell 116, 577-589.[Medline]
Shcherbina, A., Kenney, D. M., Bretscher, A. and Remold, O. D. E. (1999). Dynamic association of moesin with the membrane skeleton of thrombin-activated platelets. Blood 93, 2128-2129.
Shrimpton, C. N., Borthakur, G., Larrucea, S., Cruz, M. A., Dong, J. F. and Lopez, J. A. (2002). Localization of the adhesion receptor glycoprotein Ib-IX-V complex to lipid rafts is required for platelet adhesion and activation. J. Exp. Med. 196, 1057-1066.
Simons, K. and Toomre, D. (2000). Lipid rafts and signal transduction. Nat. Rev. 1, 31-39.[CrossRef]
Tolias, K. F., Hartwig, J. H., Ishihara, H., Shibasaki, Y., Cantley, L. C. and Carpenter, C. L. (2000). Type Ialpha phosphatidylinositol-4-phosphate 5-kinase mediates Rac-dependent actin assembly. Curr. Biol. 10, 153-156.[CrossRef][Medline]
Trumel, C., Payrastre, B., Plantavid, M., Hechler, B., Viala, C., Presek, P., Martinson, E. A., Cazenave, J. P., Chap, H. and Gachet, C. (1999). A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. Blood 94, 4156-4165.
Tuszynski, G. P., Mauco, G. P., Koshy, A., Schick, P. K. and Walsh, P. N. (1984). The platelet cytoskeleton contains elements of the prothrombinase complex. J. Biol. Chem. 259, 6947-6951.
Villalba, M., Bi, K., Rodriguez, F., Tanaka, Y., Schoenberger, S. and Altman, A. (2001). Vav1/Rac-dependent actin cytoskeleton reorganization is required for lipid raft clustering in T cells. J. Cell Biol. 155, 331-338.
Wonerow, P., Obergfell, A., Wilde, J. I., Bobe, R., Asazuma, N., Brdicka, T., Leo, A., Schraven, B., Horejsi, V., Shattil, S. J. et al. (2002). Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in platelets. Biochem. J. 364, 755-765.[CrossRef][Medline]
Zucker, M. B. and Masiello, N. C. (1983). The Triton X-100-insoluble residue of aggregated platelets contains increased lipid phosphorus as well as 125I-labeled glycoproteins. Blood 61, 676-683.[Medline]
|